C4 Therapeutics, Inc. (CCCC)
2.82
+0.12
(+4.44%)
USD |
NASDAQ |
Apr 02, 16:00
2.805
-0.02
(-0.53%)
After-Hours: 20:00
C4 Therapeutics EPS Diluted (Quarterly) : -0.1754 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Align Technology, Inc. | 1.892 |
| Biogen, Inc. | -0.3333 |
| BrightSpring Health Services, Inc. | 0.3529 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.49M |
| Revenue (Quarterly) | 11.02M |
| Total Expenses (Quarterly) | 31.50M |
| Enterprise Value | 86.62M |
| Gross Profit Margin (Quarterly) | 83.61% |
| Profit Margin (Quarterly) | -186.0% |
| Earnings Yield | -48.11% |
| Normalized Earnings Yield | -44.44 |